EGLBX
Price
$28.62
Change
-$0.05 (-0.17%)
Updated
Dec 2 closing price
Net Assets
165.24M
VTIAX
Price
$40.30
Change
+$0.12 (+0.30%)
Updated
Dec 3 closing price
Net Assets
554.27B
Interact to see
Advertisement

EGLBX vs VTIAX

Header iconEGLBX vs VTIAX Comparison
Open Charts EGLBX vs VTIAXBanner chart's image
Elfun International Equity
Price$28.62
Change-$0.05 (-0.17%)
VolumeN/A
Net Assets165.24M
Vanguard Total Intl Stock Index Admiral
Price$40.30
Change+$0.12 (+0.30%)
VolumeN/A
Net Assets554.27B
EGLBX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
EGLBX vs. VTIAX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EGLBX is a Buy and VTIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. EGLBX (165M). VTIAX pays higher dividends than EGLBX: VTIAX (2.69) vs EGLBX (1.39). EGLBX was incepted earlier than VTIAX: EGLBX (38 years) vs VTIAX (15 years). EGLBX (0.38) is less costly to investors than VTIAX (0.09). EGLBX is a more actively managed with annual turnover of: 12.00 vs. VTIAX (3.00). EGLBX has a lower initial minimum investment than VTIAX: EGLBX (500) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 21.80 vs. EGLBX (10.84). VTIAX return over 5 years is better than : 31.66 vs. EGLBX (21.72).
EGLBXVTIAXEGLBX / VTIAX
Total Expense Ratio0.380.09422%
Annual Report Gross Expense Ratio0.380.09422%
Fund Existence38 years15 years-
Gain YTD19.40926.94772%
Front LoadN/AN/A-
Min. Initial Investment500300017%
Min. Initial Investment IRAN/AN/A-
Net Assets165M554B0%
Annual Yield % from dividends1.392.6951%
Returns for 1 year10.8421.8050%
Returns for 3 years31.6642.0875%
Returns for 5 years21.7231.6669%
Returns for 10 years67.5573.2392%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX46.75N/A
N/A
Patient Opportunity A
ANCIX15.23N/A
N/A
Ancora MicroCap I
HFQIX7.21N/A
N/A
Janus Henderson Global Equity Income I
TASMX30.16N/A
N/A
Transamerica Small/Mid Cap Value R6
TRDIX8.65N/A
N/A
Transamerica Sustainable Equity Inc I2